Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/8758262

Download in:

View as

General Info

PMID
8758262